It’s time to cut through the hype, dig deep and determine how artificial intelligence can be deployed effectively in pharma-biotech companies today. Then we can project how it will transform the industry in the new decade.
And let us not forget that AI is just a part of the ever-expanding data landscape in healthcare and life sciences. From the use of real world evidence in market access to concerns around who owns and controls patient data, a whole new spectrum of opportunities and risks is emerging.
Join us at the FT Pharma AI and Data Summit in Boston on October 1, 2020, for detailed insights on the latest data applications and how to make the most of them.